Company Analysis Edwards Lifesciences Corporation
1. Summary
Advantages
- Price (74.99 $) is less than fair price (113.23 $)
- The stock's return over the last year (-10.11%) is higher than the sector average (-21.87%).
- Current debt level 5.36% is below 100% and has decreased over 5 years from 10.46%.
- The company's current efficiency (ROE=50.15%) is higher than the sector average (ROE=-83.36%)
Disadvantages
- Dividends (0%) are below the sector average (1.26%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Edwards Lifesciences Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | 4.2% | -43.1% | 1.6% |
| 90 days | 9.4% | -21% | 4.7% |
| 1 year | -10.1% | -21.9% | 12.2% |
EW vs Sector: Edwards Lifesciences Corporation has outperformed the "Healthcare" sector by 11.76% over the past year.
EW vs Market: Edwards Lifesciences Corporation has significantly underperformed the market by -22.36% over the past year.
Stable price: EW is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: EW with weekly volatility of -0.1944% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (74.99 $) is lower than the fair price (113.23 $).
Price significantly below the fair price: The current price (74.99 $) is 51% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (10.66) is lower than that of the sector as a whole (53.14).
P/E vs Market: The company's P/E (10.66) is lower than that of the market as a whole (62.2).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.42) is lower than that of the sector as a whole (10.86).
P/BV vs Market: The company's P/BV (4.42) is lower than that of the market as a whole (20.84).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (8.18) is higher than that of the sector as a whole (4.06).
P/S vs Market: The company's P/S indicator (8.18) is lower than that of the market as a whole (16.02).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (24.46) is higher than that of the sector as a whole (16.98).
EV/Ebitda vs Market: The company's EV/Ebitda (24.46) is lower than that of the market as a whole (27.16).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 81.4% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (81.4%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-10.32%).
5.4. ROE
ROE vs Sector: The company's ROE (50.15%) is higher than that of the sector as a whole (-83.36%).
ROE vs Market: The company's ROE (50.15%) is higher than that of the market as a whole (43.08%).
5.5. ROA
ROA vs Sector: The company's ROA (37.24%) is higher than that of the sector as a whole (6.41%).
ROA vs Market: The company's ROA (37.24%) is higher than that of the market as a whole (23.27%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (25.64%) is higher than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (25.64%) is higher than that of the market as a whole (9.29%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.26%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (12.11%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
